-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R+I/xi1bPKEYMtcOFPRHqNd4SSeRA3hJRPuOByMjc6JfLLkKYke3qLk9cYS/s2i8 zA+eQzFfWwxgTPL+7EIngA== 0001324517-07-000065.txt : 20070718 0001324517-07-000065.hdr.sgml : 20070718 20070718185801 ACCESSION NUMBER: 0001324517-07-000065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070702 FILED AS OF DATE: 20070718 DATE AS OF CHANGE: 20070718 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nader Francois CENTRAL INDEX KEY: 0001365343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 07987499 BUSINESS ADDRESS: BUSINESS PHONE: 801-583-4939 MAIL ADDRESS: STREET 1: 383 COLOROW DRIVE CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-07-02 0000890465 NPS PHARMACEUTICALS INC NPSP 0001365343 Nader Francois 383 COLOROW DRIVE SALT LAKE CITY UT 84108 0 1 0 0 Chief Medical & Commercial Off Stock Option 4.13 2007-07-02 4 A 0 64500 0 A 2008-07-02 2017-07-02 Common Stock 64500 64500 D Stock Option 4.42 2007-07-16 4 A 0 8875 0 A 2008-07-16 2017-07-16 Common Stock 8875 8875 D Stock option granted under the 1998 Stock Option Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter. Val R. Antczak 2007-07-18 -----END PRIVACY-ENHANCED MESSAGE-----